Outlook Therapeutics, Inc. — filings

CIK 1649989

Aggregates

computed from the filings below
Documents on record
7
Form types used
3
Filed in last 12 months
7
Median interval
9 d
between consecutive filings
Most used form
8-K
5 filings
Most recent filing
2026-09-18
Filed on a Friday
3
of the filings shown
Earliest shown
2026-07-16

By form type

FormFilingsMost recent
8-K52026-09-18
10-Q12026-08-18
424B312026-07-21

Documents

7 most recent shown
FiledFormAccessionSource
2026-09-188-K0001104659-26-108952document
2026-08-278-K0001104659-26-102446document
2026-08-1810-Q0001104659-26-098415document
2026-07-248-K0001104659-26-086685document
2026-07-248-K0001104659-26-086406document
2026-07-21424B30001104659-26-085430document
2026-07-168-K0001104659-26-084242document

Source: U.S. Securities and Exchange Commission, EDGAR

Outlook Therapeutics, Inc. filings — 7 documents on record — investment.com